Exact Sciences CORP (EXAS) — 10-Q Filings

All 10-Q filings from Exact Sciences CORP. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Exact Sciences Narrows Q3 Loss on Strong Revenue Growth — Nov 3, 2025 Risk: medium
EXACT SCIENCES CORP (EXAS) reported a net loss of $19.594 million for the three months ended September 30, 2025, a significant improvement from the $38.236 mill
Exact Sciences Q2 Loss Widens to $100M Despite 15% Revenue Jump — Aug 6, 2025 Risk: medium
EXACT SCIENCES CORP reported a net loss of $100.0 million for the three months ended June 30, 2025, a significant increase from the net loss of $75.0 million fo
Exact Sciences Corp. Files Q1 2025 10-Q — May 1, 2025 Risk: medium
Exact Sciences Corp. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial position and operational perform
Exact Sciences Files Q3 2024 10-Q — Nov 5, 2024 Risk: medium
Exact Sciences Corp. reported its third-quarter 2024 results, with the filing dated November 5, 2024. The company's fiscal year ends on December 31st. Key finan
Exact Sciences Corp. Files Q2 2024 10-Q — Jul 31, 2024 Risk: low
Exact Sciences Corp. reported its financial results for the period ending June 30, 2024. The company's filing provides details on its financial position and per
Exact Sciences Corp. Files 10-Q for Q1 2024 — May 8, 2024 Risk: medium
EXACT SCIENCES CORP (EXAS) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Exact Sciences Corp. filed its 10-Q report for the period ending March 3

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX